- Report
- October 2021
- 126 Pages
Global
From €3803EUR$4,000USD£3,195GBP
- Report
- December 2023
- 250 Pages
Global
€4749EUR$4,995USD£3,989GBP
- Report
- July 2023
- 220 Pages
Global
€4368EUR$4,595USD£3,670GBP
- Report
- August 2020
- 140 Pages
Global
€3990EUR$4,496USD£3,469GBP
- Report
- October 2023
- 116 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- September 2024
- 123 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- February 2024
- 71 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- August 2024
- 83 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- March 2024
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Report
- March 2024
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Book
- February 2012
- 216 Pages
- Book
- August 2018
- 352 Pages

The Microneedle market is a subset of the Infusions and Injectables market, which includes a variety of medical devices used to deliver drugs, fluids, and other substances into the body. Microneedles are a type of medical device that use tiny needles to deliver drugs, fluids, and other substances into the body. They are designed to be less painful and more efficient than traditional needles, and can be used to deliver drugs, fluids, and other substances directly to the target area. Microneedles are used in a variety of medical applications, including drug delivery, pain management, and wound healing.
Some companies in the Microneedle market include 3M, BD, Johnson & Johnson, Merck, and Novartis. Show Less Read more